Chemical & Pharmaceutical Structure Analysis
Where Technology and Solutions Meet

CPSA 2011

Science and Technology Coming Together to Make a Difference

October 3 - 6, 2011
Bucks County Sheraton Hotel
Langhorne, PA


Poster Abstract #18

A Sensitive Assay for the Measurement of Endogenous Levels of Angiotensin Peptides as a Biomarker Utilizing HPLC-MS/MS Detection

Jonathan Kehler, Matthew Szapacs and Neha Akella

GlaxoSmithKline Pharmaceuticals Bioanalytical Science and Toxicokinetics, PTS DMPK King of Prussia, PA USA

Angiotensin is a potent vasoconstrictor. When circulating in the body Angiotensin I is converted to Angiotensin II by cleavage of the dipeptide histidine-Leucine from the C-terminus of Angiotensin I by the Angiotensin converting enzyme (ACE). Angiotensin II is converted to Ang 1-7 by Angiotensin converting enzyme 2 (ACE2) which is further broken down to Ang 1-5.

A method for the determination of Ang II, Ang 1-7 and Ang1-5 was developed using LC-MS/MS and a one run validation was successful for the range of 5 to 1000 pg/mL for Angiotensin II and 1 -7 and 10 to 1000 pg/mL for Angiotensin 1-5. All precision and bias values were +/- 20% which meets acceptance criteria. Angiotensin II and 1-7 were quantitated to support two toxicology studies which provided critical biomarker data for the project. The method is sensitive, selective and robust which successfully analyzed in vivo study samples

Return to program

©2011 Milestone Development Services. All rights reserved.